Cardiologist manages diseases of the cardiovascular system and prevents the development of these diseases. Though, the cardiologist of the oncology clinic provides prevention, timely diagnosis, and effective treatment of cardiotoxicity and other cardiovascular complications in oncology patients during anti-cancer therapy.
Introduction of a new and effective anti-cancer drugs often is associated with a high risk of cardiovascular complications. In particular, chemotherapy with targeted drugs sometimes leads to increased incidence of their side effects and can also influence the transition from one type of cardiotoxicity to another. Cardiotoxicity is a term that involves different undesirable events, related to the cardiovascular system during drug therapy in oncology patients. It can occur during or after treatment.
Therefore, during the chemotherapy or target therapy, monitoring of cardiovascular system is necessary for timely diagnostics and effective treatment of cardiovascular complications.
The importance of regular monitoring by a cardiologist is justified by the fact that 50% of mortality in cancer-cured patients is due to heart failure.
The most important principle of the Institute of Clinical Oncology is a multidisciplinary approach, therefore our patients are monitored by both an oncologist and a cardiologist, who are familiar with early signs of heart failure during anti-cancer treatment. The timely involvement of a cardiologist significantly improves the quality and duration of the patient's life.
At ICO, the cardiologist performs: differential diagnostics between the increasing complication of cardiac pathology and the deterioration associated with the progression of oncological disease;
At ICO, the cardiologist is involved in the patient’s condition monitoring mechanism from the very beginning:
Dont miss Koi news
